Biocryst Pharmaceuticals Stock
Biocryst Pharmaceuticals Stock
Heavy losses for Biocryst Pharmaceuticals today as the stock fell by -€0.244 (-3.400%).
With 14 Buy predictions and not the single Sell prediction the community is currently very high on Biocryst Pharmaceuticals.
Based on the current price of 7.12 € the target price of 15 € shows a potential of 110.73% for Biocryst Pharmaceuticals which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Biocryst Pharmaceuticals stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Biocryst Pharmaceuticals in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biocryst Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals | -3.400% | -9.302% | -8.860% | -27.721% | 8.572% | -8.533% | -47.176% |
| Heron Therapeutics Inc. | -2.590% | -50.938% | -62.314% | -78.209% | -65.494% | -63.390% | -96.604% |
| Evolus Inc | -0.460% | -0.569% | 14.692% | -37.643% | -3.890% | -35.730% | -42.122% |
| Rhythm Pharmaceuticals | -0.690% | -8.917% | 3.623% | 32.407% | -23.529% | 335.976% | 367.320% |
Comments
BioCryst Pharmaceuticals (BCRX) had its price target lowered by Wedbush from $22.00 to $21.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BCRX provided by MarketBeat
BioCryst Pharmaceuticals (BCRX) had its price target lowered by Needham & Company LLC from $18.00 to $16.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BCRX provided by MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
Show more
Ratings data for BCRX provided by MarketBeat